세계의 상처 치료 시장 : 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Wound Care Market was valued at USD 24.9 billion in 2024 and is estimated to grow at a CAGR of 5.9% to reach USD 44.2 billion by 2034. Wound care plays a critical role in healthcare by encompassing a wide range of medical products and solutions that support the healing of wounds, prevent complications, and reduce the risk of infections. With the rising global burden of chronic diseases, an increasing geriatric population, and a growing number of surgical procedures, the demand for advanced and effective wound care solutions continues to accelerate. The market is experiencing a significant boost due to heightened awareness around wound management, increasing healthcare expenditure, and the rapid adoption of modern treatment approaches.

Hospitals, outpatient care centers, and home healthcare settings are witnessing a surge in the use of specialized wound care products as healthcare professionals seek faster healing, reduced hospital stays, and improved patient outcomes. In addition, the surge in road accidents, burn injuries, and sports-related trauma is also pushing demand for efficient wound healing products globally. Regulatory support, reimbursement policies, and technological advancements such as smart dressings and bioengineered skin substitutes are expected to further expand the market's potential.

Wound dressing products remain at the core of the wound care segment, with product selection depending heavily on the wound type and severity. The market is segmented into advanced surgical wound care, wound dressing, wound therapy devices, traditional wound care, and wound care biologics. Among these, the advanced wound dressing segment is poised for robust growth, projected to generate USD 14.5 billion by 2034. These dressings are designed to optimize moisture balance, promote tissue regeneration, and minimize scab formation, all of which accelerate healing. Many of these products feature antimicrobial components such as silver, iodine, or honey, effectively lowering infection risk and promoting a clean wound environment. Additionally, non-adherent and silicone-based dressings reduce discomfort during dressing changes and protect delicate new tissues from trauma.

The wound care market is further categorized based on wound type-chronic and acute. The acute wound care segment, which includes surgical wounds, trauma injuries, and burns, accounted for USD 13.9 billion in revenue in 2024. Products such as foam dressings, hydrogels, and film dressings are widely used to manage these wounds and prevent infection. Advanced solutions like silicone and hydrogel dressings are gaining traction for their ability to minimize pain and irritation during dressing changes, driving further demand in this segment.

The U.S. Wound Care Market is anticipated to reach USD 11.9 billion by 2034, driven by the growing prevalence of chronic wounds and an aging population. With a highly developed healthcare infrastructure, increasing diabetes cases, and rising patient awareness, the U.S. remains a major contributor to the global wound care landscape.

Key players shaping the global wound care market include 3M Company, Baxter International, Medline Industries, B. Braun Melsungen, Molnlycke Health Care, Smith and Nephew, ConvaTec Group, Medtronic, Coloplast, Johnson & Johnson, Derma Sciences, and Integra LifeSciences. These companies focus on continuous innovation, launching advanced wound care products with bioactive materials and antimicrobial technologies. Many are also expanding their portfolios and strengthening distribution networks to tap into emerging markets and improve global accessibility.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of surgical procedures
    • 3.2.1.2 Rising demand for wound care products
    • 3.2.1.3 Rising prevalence of diabetes
    • 3.2.1.4 Growing technological advancements in wound care products
    • 3.2.1.5 Rise in number of trauma cases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Availability of alternative therapies
    • 3.2.2.2 Improper wound management due to lack of awareness of advanced wound care products in emerging economies
    • 3.2.2.3 Prolonged diagnosis of chronic wounds in developing countries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Patent analysis
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Products, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Advanced wound dressing
  • 5.2.1 Foam dressings
  • 5.2.2 Hydrocolloid dressings
  • 5.2.3 Film dressings
  • 5.2.4 Alginate dressings
  • 5.2.5 Hydrogel dressings
  • 5.2.6 Collagen dressings
  • 5.2.7 Other advanced dressings
• 5.3 Surgical wound care
  • 5.3.1 Sutures and staples
  • 5.3.2 Tissue adhesive and sealants
  • 5.3.3 Anti-infective dressing
• 5.4 Traditional wound care
  • 5.4.1 Medical tapes
  • 5.4.2 Cotton
  • 5.4.3 Bandages
  • 5.4.4 Gauzes
  • 5.4.5 Sponges
  • 5.4.6 Cleansing agents
• 5.5 Wound therapy devices
  • 5.5.1 Negative pressure wound therapy
  • 5.5.2 Oxygen and hyperbaric oxygen equipment
  • 5.5.3 Electric stimulation devices
  • 5.5.4 Pressure relief devices
  • 5.5.5 Other wound therapy devices
• 5.6 Wound care biologics
  • 5.6.1 Skin substitutes
    • 5.6.1.1 Biological
      • 5.6.1.1.1 Allograft
      • 5.6.1.1.2 Xenograft
      • 5.6.1.1.3 Other biologicals
    • 5.6.1.2 Synthetic
  • 5.6.2 Topical agents

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Chronic wounds
  • 6.2.1 Diabetic foot ulcers
  • 6.2.2 Pressure ulcers
  • 6.2.3 Venous leg ulcers
  • 6.2.4 Other chronic wounds
• 6.3 Acute wounds
  • 6.3.1 Surgical wounds
  • 6.3.2 Traumatic wounds
  • 6.3.3 Burns

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Home care settings
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Russia
  • 8.3.7 Czech Republic
  • 8.3.8 Netherlands
  • 8.3.9 Denmark
  • 8.3.10 Hungary
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 3M Company
• 9.2 Advancis Medical
• 9.3 B. Braun Melsungen
• 9.4 Baxter International
• 9.5 Coloplast
• 9.6 ConvaTec Group
• 9.7 Ethicon (Johnson and Johnson)
• 9.8 Derma Sciences (Integra LifeSciences)
• 9.9 Medline Industries
• 9.10 Medtronic
• 9.11 Molnlycke Health Care
• 9.12 Smith and Nephew
• 9.13 URGO Medical